Opendata, web and dolomites

iRhom2 in AD SIGNED

iRhom2 in neuroinflammation and pathogenesis of Alzheimer’s Disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 iRhom2 in AD project word cloud

Explore the words cloud of the iRhom2 in AD project. It provides you a very rough idea of what is the project "iRhom2 in AD" about.

cell    healthy    clients    functional    plasma    events    model    traffic    pro    guide    dementia    rheumatoid    tace    plan    protected    dependent    candidates    dramatic    line    garde    cognitive    form    memory    begins    membrane    assays    cascade    implicated    near    regulate    genetic    though    play    avant    converting    validated    citizens    enzyme    disease    socio    diseases    neuron    biochemical    signalling    progression    risk    macrophages    maturation    rhomboid    inflammatory    regulating    array    elderly    protein    sepsis    worsen    cure    mechanism    culminating    involve    decline    death    irhom2    tnf    ageing    cross    thereby    necrosis    unless    oligomers    pathology    alzheimer    arthritis    inflammation    emerged    neuroinflammation    proteomic    release    additional    consequently    alpha    accumulation    underlying    triggered    mice    beta    tangles    syndrome    therapies    found    ad    cytokine    tumor    primary    foreseen    trafficking    neurofibrillary    mouse    economical    treatment   

Project "iRhom2 in AD" data sheet

The following table provides information about the project.

Coordinator
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN 

Organization address
address: ISMANINGER STRASSE 22
city: MUENCHEN
postcode: 81675
website: http://www.med.tu.muenchen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website http://www.sciencedirect.com/science/article/pii/S0945053X16301329
 Total cost 159˙460 €
 EC max contribution 159˙460 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2015
 Duration (year-month-day) from 2015-12-01   to  2017-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN DE (MUENCHEN) coordinator 159˙460.00

Map

 Project objective

Alzheimer’s disease (AD) is the most common form of dementia in the elderly, a syndrome characterized by loss of memory and cognitive decline. AD has a dramatic socio-economical impact that is foreseen to worsen in the near future unless a cure is found. The pathology is triggered by the accumulation of Aβ oligomers that begins a cascade culminating with the formation of neurofibrillary tangles within the neuron and cell death. Neuroinflammation is emerging to play a key role in this process and it has been associated with the progression of the disease. The rhomboid-like protein iRhom2 has been recently identified as a genetic risk factor for AD, even though the underlying mechanism remains to be characterized. iRhom2 recently emerged as a novel pro-inflammatory protein required to traffic TACE (tumor necrosis factor-α converting enzyme) towards the plasma membrane and guide its maturation, thereby regulating the release of TNFα, a cytokine implicated in several inflammatory diseases. Consequently, iRhom2-/- mice are protected from sepsis and rheumatoid arthritis, which involve TNFα-dependent inflammation. In addition, the concept is emerging that iRhom2 may regulate trafficking of additional clients other than TACE, thus controlling other signalling events in neuroinflammation. The main objective of this proposal is to characterize the role of iRhom2 in neuroinflammation and in the progression of AD. I plan to cross an AD mouse model with iRhom2-/- mice and evaluate role of iRhom2 in the progression of the disease. In addition, I will use avant-garde proteomic approaches to identify novel iRhom2 clients in primary macrophages. Candidates relevant in neuroinflammation and AD will be further validated using an array of biochemical and functional assays. From this research I aim to identify new targets to develop therapies for treatment of AD, in line with the objectives of H2020 Work Programme to promote healthy ageing of the EU citizens.

 Publications

year authors and title journal last update
List of publications.
2016 Simone D. Scilabra, Kazuhiro Yamamoto, Martina Pigoni, Kazuma Sakamoto, Stephan A. Müller, Alkmini Papadopoulou, Stefan F. Lichtenthaler, Linda Troeberg, Hideaki Nagase, Kenji Kadomatsu
Dissecting the interaction between tissue inhibitor of metalloproteinases-3 (TIMP-3) and low density lipoprotein receptor-related protein-1 (LRP-1): Development of a “TRAP” to increase levels of TIMP-3 in the tissue
published pages: , ISSN: 0945-053X, DOI: 10.1016/j.matbio.2016.07.004
Matrix Biology 2019-06-14
2016 Stephan A. Müller, Simone D. Scilabra, Stefan F. Lichtenthaler
Proteomic Substrate Identification for Membrane Proteases in the Brain
published pages: , ISSN: 1662-5099, DOI: 10.3389/fnmol.2016.00096
Frontiers in Molecular Neuroscience 9 2019-06-14

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IRHOM2 IN AD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IRHOM2 IN AD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

MingleIFT (2020)

Multi-color and single-molecule fluorescence imaging of intraflagellar transport in the phasmid chemosensory cilia of C. Elegans

Read More  

DiMaS (2019)

Retrospective genomic analyses of shortfin Mako shark (Isurus oxyrinchus) using DNA from archived jaws

Read More  

MIGPSC (2018)

Shaping the European Migration Policy: the role of the security industry

Read More